148 related articles for article (PubMed ID: 33164593)
21. Twelve-month Continuation of the Etonogestrel Implant in Adolescents With Polycystic Ovary Syndrome.
Buyers E; Sass AE; Severn CD; Pyle L; Cree-Green M
J Pediatr Adolesc Gynecol; 2021 Feb; 34(1):33-39. PubMed ID: 32919086
[TBL] [Abstract][Full Text] [Related]
22. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.
Ali M; Akin A; Bahamondes L; Brache V; Habib N; Landoulsi S; Hubacher D;
Hum Reprod; 2016 Nov; 31(11):2491-2498. PubMed ID: 27671673
[TBL] [Abstract][Full Text] [Related]
23. Treatment of rectovaginal endometriosis with the etonogestrel-releasing contraceptive implant.
Ferrero S; Scala C; Ciccarelli S; Vellone VG; Barra F
Gynecol Endocrinol; 2020 Jun; 36(6):540-544. PubMed ID: 31711348
[TBL] [Abstract][Full Text] [Related]
24. Long acting reversible contraception in postpartum adolescents: early initiation of etonogestrel implant is superior to IUDs in the outpatient setting.
Tocce K; Sheeder J; Python J; Teal SB
J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):59-63. PubMed ID: 22051792
[TBL] [Abstract][Full Text] [Related]
25. Relationship Between Etonogestrel Concentrations and Bleeding Patterns in Contraceptive Implant Users.
Lazorwitz A; Aquilante CL; Dindinger E; Harrison M; Sheeder J; Teal S
Obstet Gynecol; 2019 Oct; 134(4):807-813. PubMed ID: 31503152
[TBL] [Abstract][Full Text] [Related]
26. Timing of Etonogestrel-Releasing Implants and Growth of Breastfed Infants: A Randomized Controlled Trial.
Carmo LSMP; Braga GC; Ferriani RA; Quintana SM; Vieira CS
Obstet Gynecol; 2017 Jul; 130(1):100-107. PubMed ID: 28594758
[TBL] [Abstract][Full Text] [Related]
27. A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant.
Apter D; Briggs P; Tuppurainen M; Grunert J; Lukkari-Lax E; Rybowski S; Gemzell-Danielsson K
Fertil Steril; 2016 Jul; 106(1):151-157.e5. PubMed ID: 27016644
[TBL] [Abstract][Full Text] [Related]
28. One-year follow-up of immediate postpartum contraceptive implant insertion in adolescents.
Barbieri MM; Dantas-Silva A; Caleffi LS; Morais SS; Juliato CRT; Bahamondes L; Surita FG
Eur J Contracept Reprod Health Care; 2023 Feb; 28(1):58-64. PubMed ID: 36287505
[TBL] [Abstract][Full Text] [Related]
29. Continuation of the etonogestrel implant in women undergoing immediate postabortion placement.
Madden T; Eisenberg DL; Zhao Q; Buckel C; Secura GM; Peipert JF
Obstet Gynecol; 2012 Nov; 120(5):1053-9. PubMed ID: 23090522
[TBL] [Abstract][Full Text] [Related]
30. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study.
Brito MB; Ferriani RA; Quintana SM; Yazlle ME; Silva de Sá MF; Vieira CS
Contraception; 2009 Dec; 80(6):519-26. PubMed ID: 19913145
[TBL] [Abstract][Full Text] [Related]
31. Administration of the etonogestrel contraceptive implant on the day of mifepristone for medical abortion: a pilot study.
Sonalkar S; Hou MY; Borgatta L
Contraception; 2013 Nov; 88(5):671-3. PubMed ID: 24028749
[TBL] [Abstract][Full Text] [Related]
32. One-year continuation of the etonogestrel contraceptive implant in women with postabortion or interval placement.
Mark A; Sonalkar S; Borgatta L
Contraception; 2013 Nov; 88(5):619-23. PubMed ID: 23790436
[TBL] [Abstract][Full Text] [Related]
33. A multicenter randomized clinical trial of etonogestrel and levonorgestrel contraceptive implants with nonrandomized copper intrauterine device controls: effect on weight variations up to 3 years after placement.
Bahamondes L; Brache V; Ali M; Habib N;
Contraception; 2018 Sep; 98(3):181-187. PubMed ID: 29777663
[TBL] [Abstract][Full Text] [Related]
34. Acceptability of ENG-releasing subdermal implants among postpartum Brazilian young women during the COVID-19 pandemic.
Barbieri MM; Herculano TB; Dantas Silva A; Bahamondes L; Juliato CRT; Surita FG
Int J Gynaecol Obstet; 2021 Jul; 154(1):106-112. PubMed ID: 33656758
[TBL] [Abstract][Full Text] [Related]
35. Quality of life of women using the etonogestrel long-acting reversible contraceptive implant after abortion for unplanned pregnancy.
Caruso S; Vitale SG; Fava V; Pasqua SD; Rapisarda AMC; Cianci S
Eur J Contracept Reprod Health Care; 2020 Aug; 25(4):251-258. PubMed ID: 32436733
[TBL] [Abstract][Full Text] [Related]
36. Lactogenesis and breastfeeding after immediate vs delayed birth-hospitalization insertion of etonogestrel contraceptive implant: a noninferiority trial.
Henkel A; Lerma K; Reyes G; Gutow H; Shaw JG; Shaw KA
Am J Obstet Gynecol; 2023 Jan; 228(1):55.e1-55.e9. PubMed ID: 35964661
[TBL] [Abstract][Full Text] [Related]
37. Informing Policy Change: A Study of Rapid Repeat Pregnancy in Adolescents to Increase Access to Immediate Postpartum Contraception.
Qasba NT; Stutsman JW; Weaver GE; Jones KE; Daggy JK; Wilkinson TA
J Womens Health (Larchmt); 2020 Jun; 29(6):815-818. PubMed ID: 31990605
[No Abstract] [Full Text] [Related]
38. Rapid repeat pregnancy in adolescents: do immediate postpartum contraceptive implants make a difference?
Tocce KM; Sheeder JL; Teal SB
Am J Obstet Gynecol; 2012 Jun; 206(6):481.e1-7. PubMed ID: 22631865
[TBL] [Abstract][Full Text] [Related]
39. Etonogestrel-Releasing Contraceptive Implant for Postpartum Adolescents: A Randomized Controlled Trial.
Bryant AG; Bauer AE; Stuart GS; Levi EE; Zerden ML; Danvers A; Garrett JM
J Pediatr Adolesc Gynecol; 2017 Jun; 30(3):389-394. PubMed ID: 27561981
[TBL] [Abstract][Full Text] [Related]
40. Cost-Effectiveness of Immediate Compared With Delayed Postpartum Etonogestrel Implant Insertion.
Gariepy AM; Duffy JY; Xu X
Obstet Gynecol; 2015 Jul; 126(1):47-55. PubMed ID: 26241255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
